| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.975 | 0.001 | 0.975 | Aldehyde oxidase inhibitor | 0.898 0.003 CID_10451115 0.961 0.002 CID_82341 | ||
| 0.715 | 0.022 | 0.729 | Caspase 9 stimulant | 0.729 0.02 CID_10451115 0.385 0.12 CID_82341 | CID_10451115 | |
| 0.641 | 0.007 | 0.641 | Histamine release inhibitor | 0.482 0.036 CID_10451115 0.512 0.025 CID_82341 | ||
| 0.63 | 0.01 | 0.63 | Spasmolytic | 0.497 0.023 CID_10451115 0.445 0.032 CID_82341 | ||
| 0.567 | 0.008 | 0.599 | Anticonvulsant | 0.587 0.008 CID_10451115 0.599 0.007 CID_82341 | CID_82341 | |
| 0.538 | 0.004 | 0.651 | Histamine H1 receptor antagonist | 0.437 0.004 CID_10451115 0.651 0.003 CID_82341 | CID_82341 | |
| 0.474 | 0.008 | 0.474 | Cyclic AMP phosphodiesterase inhibitor | 0.47 0.009 CID_10451115 0.258 0.06 CID_82341 | ||
| 0.462 | 0.004 | 0.462 | Dopamine D1 antagonist | 0.421 0.004 CID_10451115 0.201 0.01 CID_82341 | ||
| 0.459 | 0.004 | 0.459 | Nav1.3 sodium channel blocker | 0.389 0.005 CID_10451115 0.22 0.019 CID_82341 | ||
| 0.423 | 0.006 | 0.423 | Nav1.2 sodium channel blocker | 0.394 0.007 CID_10451115 0.197 0.036 CID_82341 | ||
| 0.42 | 0.007 | 0.555 | Dopamine antagonist | 0.555 0.005 CID_10451115 0.38 0.008 CID_82341 | CID_10451115 | |
| 0.437 | 0.026 | 0.437 | Vasodilator, coronary | 0.398 0.036 CID_10451115 0.302 0.086 CID_82341 | ||
| 0.419 | 0.008 | 0.594 | 5 Hydroxytryptamine 2B antagonist | 0.594 0.004 CID_10451115 0.172 0.033 CID_82341 | CID_10451115 | |
| 0.408 | 0.009 | 0.601 | 5 Hydroxytryptamine 2 antagonist | 0.601 0.004 CID_10451115 0.162 0.04 CID_82341 | CID_10451115 | |
| 0.383 | 0.006 | 0.64 | 5 Hydroxytryptamine 2C antagonist | 0.64 0.004 CID_10451115 0.145 0.028 CID_82341 | CID_10451115 | |
| 0.383 | 0.008 | 0.5 | Dopamine D2 antagonist | 0.5 0.005 CID_10451115 0.381 0.008 CID_82341 | CID_10451115 | |
| 0.378 | 0.01 | 0.591 | Alpha adrenoreceptor antagonist | 0.591 0.005 CID_10451115 0.126 0.045 CID_82341 | CID_10451115 | |
| 0.365 | 0.008 | 0.548 | 5 Hydroxytryptamine 2A antagonist | 0.548 0.004 CID_10451115 0.129 0.034 CID_82341 | CID_10451115 | |
| 0.357 | 0.005 | 0.411 | Dopamine D4 antagonist | 0.411 0.005 CID_10451115 0.112 0.023 CID_82341 | CID_10451115 | |
| 0.328 | 0.009 | 0.496 | Alpha 1 adrenoreceptor antagonist | 0.496 0.005 CID_10451115 0.119 0.037 CID_82341 | CID_10451115 | |
| 0.324 | 0.01 | 0.324 | Anesthetic local | 0.216 0.028 CID_10451115 0.141 0.053 CID_82341 | ||
| 0.324 | 0.012 | 0.463 | Antiadrenergic | 0.463 0.006 CID_10451115 0.163 0.032 CID_82341 | CID_10451115 | |
| 0.318 | 0.012 | 0.455 | Adrenaline antagonist | 0.455 0.006 CID_10451115 0.158 0.032 CID_82341 | CID_10451115 | |
| 0.312 | 0.009 | 0.402 | Antihistaminic | 0.385 0.006 CID_10451115 0.402 0.006 CID_82341 | CID_82341 | |
| 0.319 | 0.017 | 0.626 | 5 Hydroxytryptamine antagonist | 0.626 0.005 CID_10451115 0.126 0.062 CID_82341 | CID_10451115 | |
| 0.296 | 0.008 | 0.442 | Alpha 1b adrenoreceptor antagonist | 0.442 0.004 CID_10451115 0.125 0.028 CID_82341 | CID_10451115 | |
| 0.297 | 0.009 | 0.581 | Alpha 2b adrenoreceptor antagonist | 0.581 0.004 CID_10451115 0.14 0.044 CID_82341 | CID_10451115 | |
| 0.302 | 0.014 | 0.306 | Acetylcholine M1 receptor antagonist | 0.306 0.013 CID_10451115 0.199 0.043 CID_82341 | CID_10451115 | |
| 0.292 | 0.01 | 0.374 | Histamine antagonist | 0.374 0.007 CID_10451115 0.35 0.008 CID_82341 | CID_10451115 | |
| 0.309 | 0.037 | 0.309 | Sigma receptor agonist | 0.292 0.04 CID_10451115 0.224 0.055 CID_82341 | ||
| 0.287 | 0.016 | 0.389 | Antipruritic | 0.242 0.027 CID_10451115 0.389 0.007 CID_82341 | CID_82341 | |
| 0.278 | 0.008 | 0.507 | Mediator release inhibitor | 0.164 0.023 CID_10451115 0.507 0.004 CID_82341 | CID_82341 | |
| 0.27 | 0.008 | 0.27 | Nav1.6 sodium channel blocker | 0.266 0.008 CID_10451115 0.149 0.055 CID_82341 | ||
| 0.262 | 0.006 | 0.405 | Alpha 1d adrenoreceptor antagonist | 0.405 0.004 CID_10451115 0.099 0.023 CID_82341 | CID_10451115 | |
| 0.263 | 0.011 | 0.442 | Alpha 1a adrenoreceptor antagonist | 0.442 0.005 CID_10451115 0.084 0.043 CID_82341 | CID_10451115 | |
| 0.259 | 0.018 | 0.259 | Adenylate cyclase inhibitor | 0.161 0.038 CID_10451115 0.122 0.066 CID_82341 | ||
| 0.242 | 0.005 | 0.242 | Sphingomyelinase inhibitor | 0.181 0.014 CID_10451115 0.143 0.028 CID_82341 | ||
| 0.284 | 0.047 | 0.411 | Psychostimulant | 0.411 0.021 CID_10451115 0.281 0.048 CID_82341 | CID_10451115 | |
| 0.252 | 0.02 | 0.387 | NADPH oxidase inhibitor | 0.387 0.005 CID_10451115 | CID_10451115 | |
| 0.239 | 0.008 | 0.338 | Dopamine D3 antagonist | 0.338 0.005 CID_10451115 0.102 0.024 CID_82341 | CID_10451115 | |
| 0.226 | 0.005 | 0.226 | Dopamine D5 antagonist | 0.179 0.005 CID_10451115 0.12 0.008 CID_82341 | ||
| 0.249 | 0.03 | 0.249 | Cytidine deaminase inhibitor | 0.23 0.035 CID_10451115 0.156 0.071 CID_82341 | ||
| 0.23 | 0.014 | 0.257 | Nav1.1 sodium channel blocker | 0.257 0.011 CID_10451115 0.131 0.041 CID_82341 | CID_10451115 | |
| 0.227 | 0.013 | 0.413 | Alpha 2c adrenoreceptor antagonist | 0.413 0.004 CID_10451115 0.102 0.064 CID_82341 | CID_10451115 | |
| 0.222 | 0.009 | 0.222 | MAP3K9 inhibitor | 0.178 0.028 CID_10451115 0.201 0.015 CID_82341 | ||
| 0.222 | 0.01 | 0.447 | 5 Hydroxytryptamine 7 antagonist | 0.447 0.005 CID_10451115 0.101 0.025 CID_82341 | CID_10451115 | |
| 0.213 | 0.003 | 0.213 | Ca2+-transporting ATPase inhibitor | 0.194 0.004 CID_10451115 0.178 0.008 CID_82341 | ||
| 0.248 | 0.039 | 0.248 | Neurotrophic factor enhancer | 0.164 0.118 CID_10451115 0.185 0.092 CID_82341 | ||
| 0.299 | 0.092 | 0.381 | Calcium channel activator | 0.381 0.033 CID_10451115 0.276 0.117 CID_82341 | CID_10451115 | |
| 0.313 | 0.106 | 0.313 | Calpain 2 inhibitor | 0.301 0.114 CID_10451115 | ||
| 0.215 | 0.009 | 0.266 | Protein kinase C zeta inhibitor | 0.266 0.006 CID_10451115 0.139 0.023 CID_82341 | CID_10451115 | |
| 0.223 | 0.023 | 0.223 | ATPase inhibitor | 0.185 0.052 CID_10451115 0.171 0.07 CID_82341 | ||
| 0.2 | 0.005 | 0.317 | Histamine N-methyltransferase inhibitor | 0.317 0.003 CID_10451115 0.123 0.028 CID_82341 | CID_10451115 | |
| 0.282 | 0.088 | 0.289 | Caspase 3 stimulant | 0.289 0.084 CID_10451115 | CID_10451115 | |
| 0.212 | 0.026 | 0.233 | Calcium channel blocker | 0.233 0.02 CID_10451115 0.197 0.031 CID_82341 | CID_10451115 | |
| 0.27 | 0.089 | 0.396 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.396 0.022 CID_10451115 | CID_10451115 | |
| 0.281 | 0.104 | 0.281 | Cholesterol antagonist | |||
| 0.197 | 0.022 | 0.233 | Butyrylcholinesterase inhibitor | 0.233 0.017 CID_10451115 | CID_10451115 | |
| 0.19 | 0.016 | 0.196 | Protein kinase C gamma inhibitor | 0.196 0.015 CID_10451115 0.144 0.035 CID_82341 | CID_10451115 | |
| 0.187 | 0.016 | 0.49 | Alpha 2a adrenoreceptor antagonist | 0.49 0.004 CID_10451115 0.066 0.063 CID_82341 | CID_10451115 | |
| 0.188 | 0.016 | 0.434 | 5 Hydroxytryptamine 1A antagonist | 0.434 0.005 CID_10451115 | CID_10451115 | |
| 0.211 | 0.04 | 0.211 | Diuretic | 0.163 0.067 CID_10451115 0.154 0.074 CID_82341 | ||
| 0.179 | 0.008 | 0.233 | Dopamine uptake inhibitor | 0.233 0.005 CID_10451115 0.105 0.017 CID_82341 | CID_10451115 | |
| 0.248 | 0.077 | 0.341 | 5 Hydroxytryptamine 1E antagonist | 0.341 0.012 CID_10451115 | CID_10451115 | |
| 0.239 | 0.071 | 0.395 | HERG channel blocker | 0.395 0.029 CID_10451115 0.2 0.091 CID_82341 | CID_10451115 | |
| 0.164 | 0.008 | 0.172 | Lanosterol 14 alpha demethylase inhibitor | 0.172 0.006 CID_10451115 0.1 0.055 CID_82341 | CID_10451115 | |
| 0.31 | 0.154 | 0.31 | 5 Hydroxytryptamine release inhibitor | 0.268 0.204 CID_10451115 | ||
| 0.212 | 0.057 | 0.225 | P-glycoprotein inhibitor | 0.168 0.092 CID_10451115 0.225 0.051 CID_82341 | CID_82341 | |
| 0.182 | 0.029 | 0.204 | Acetylcholine muscarinic antagonist | 0.204 0.023 CID_10451115 0.128 0.06 CID_82341 | CID_10451115 | |
| 0.167 | 0.014 | 0.4 | 5 Hydroxytryptamine 1F antagonist | 0.4 0.005 CID_10451115 0.063 0.056 CID_82341 | CID_10451115 | |
| 0.217 | 0.065 | 0.263 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.263 0.047 CID_10451115 | CID_10451115 | |
| 0.166 | 0.019 | 0.19 | Sphingosine 1-phosphate receptor 2 agonist | 0.19 0.013 CID_10451115 0.118 0.057 CID_82341 | CID_10451115 | |
| 0.225 | 0.078 | 0.266 | MAP-kinase-activated kinase 5 inhibitor | 0.266 0.05 CID_10451115 | CID_10451115 | |
| 0.21 | 0.069 | 0.21 | Anesthetic general | 0.151 0.112 CID_10451115 | ||
| 0.158 | 0.022 | 0.398 | 5 Hydroxytryptamine 1 antagonist | 0.398 0.006 CID_10451115 | CID_10451115 | |
| 0.217 | 0.084 | 0.346 | Potassium channel (Voltage-sensitive) blocker | 0.346 0.037 CID_10451115 0.181 0.111 CID_82341 | CID_10451115 | |
| 0.139 | 0.005 | 0.173 | 5 Hydroxytryptamine 3 agonist | 0.173 0.004 CID_10451115 0.073 0.032 CID_82341 | CID_10451115 | |
| 0.197 | 0.068 | 0.213 | 5 Hydroxytryptamine 3E antagonist | 0.213 0.044 CID_10451115 0.183 0.097 CID_82341 | CID_10451115 | |
| 0.135 | 0.013 | 0.135 | Calcium channel L-type blocker | 0.128 0.014 CID_10451115 0.093 0.028 CID_82341 | ||
| 0.164 | 0.042 | 0.172 | Adenylate cyclase stimulant | 0.172 0.033 CID_10451115 0.124 0.115 CID_82341 | CID_10451115 | |
| 0.132 | 0.018 | 0.289 | 5 Hydroxytryptamine uptake inhibitor | 0.289 0.006 CID_10451115 0.074 0.036 CID_82341 | CID_10451115 | |
| 0.16 | 0.047 | 0.209 | Cholinergic antagonist | 0.209 0.03 CID_10451115 | CID_10451115 | |
| 0.124 | 0.012 | 0.168 | Acetylcholine M5 receptor antagonist | 0.168 0.006 CID_10451115 0.063 0.038 CID_82341 | CID_10451115 | |
| 0.127 | 0.016 | 0.224 | Acetylcholine M4 receptor antagonist | 0.224 0.005 CID_10451115 0.084 0.043 CID_82341 | CID_10451115 | |
| 0.119 | 0.008 | 0.133 | Protein kinase C beta inhibitor | 0.133 0.005 CID_10451115 0.081 0.028 CID_82341 | CID_10451115 | |
| 0.296 | 0.185 | 0.296 | MAP kinase 1 inhibitor | |||
| 0.178 | 0.07 | 0.178 | Succinate dehydrogenase inhibitor | 0.163 0.091 CID_82341 | ||
| 0.28 | 0.173 | 0.28 | DNA directed DNA polymerase inhibitor | |||
| 0.11 | 0.004 | 0.11 | Adenylate cyclase 1 inhibitor | 0.096 0.005 CID_10451115 0.057 0.02 CID_82341 | ||
| 0.111 | 0.005 | 0.113 | 5 Hydroxytryptamine 4 antagonist | 0.113 0.005 CID_10451115 0.086 0.011 CID_82341 | CID_10451115 | |
| 0.136 | 0.031 | 0.37 | Alpha 2 adrenoreceptor antagonist | 0.37 0.005 CID_10451115 | CID_10451115 | |
| 0.188 | 0.085 | 0.188 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.172 0.103 CID_10451115 | ||
| 0.132 | 0.03 | 0.25 | NMDA receptor antagonist | 0.138 0.028 CID_10451115 0.25 0.009 CID_82341 | CID_82341 | |
| 0.149 | 0.047 | 0.149 | Antibacterial (Helicobacter pylori) | 0.117 0.086 CID_10451115 | ||
| 0.121 | 0.02 | 0.125 | Histamine H2 receptor antagonist | 0.125 0.018 CID_10451115 0.081 0.062 CID_82341 | CID_10451115 | |
| 0.176 | 0.075 | 0.23 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.23 0.051 CID_10451115 | CID_10451115 | |
| 0.156 | 0.056 | 0.185 | Neuropeptide Y1 antagonist | 0.185 0.026 CID_10451115 | CID_10451115 | |
| 0.154 | 0.055 | 0.183 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.091 CID_10451115 0.183 0.021 CID_82341 | CID_82341 | |
| 0.145 | 0.053 | 0.196 | Acetylcholine antagonist | 0.196 0.032 CID_10451115 | CID_10451115 | |
| 0.252 | 0.162 | 0.252 | 15-Lipoxygenase inhibitor | 0.229 0.183 CID_10451115 | ||
| 0.096 | 0.008 | 0.096 | MDM2 inhibitor | 0.084 0.016 CID_10451115 0.085 0.015 CID_82341 | ||
| 0.12 | 0.035 | 0.12 | Alcohol dehydrogenase inhibitor | 0.101 0.051 CID_82341 | ||
| 0.149 | 0.065 | 0.149 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.107 | 0.024 | 0.12 | Dopamine agonist | 0.12 0.02 CID_10451115 0.063 0.05 CID_82341 | CID_10451115 | |
| 0.082 | 0.005 | 0.082 | GABA uptake inhibitor | 0.044 0.021 CID_10451115 0.082 0.005 CID_82341 | ||
| 0.117 | 0.043 | 0.117 | Creatine kinase inhibitor | 0.102 0.057 CID_82341 | ||
| 0.092 | 0.02 | 0.122 | Phospholipase D inhibitor | 0.122 0.006 CID_10451115 0.066 0.063 CID_82341 | CID_10451115 | |
| 0.096 | 0.025 | 0.271 | 5 Hydroxytryptamine 1B antagonist | 0.271 0.005 CID_10451115 | CID_10451115 | |
| 0.223 | 0.152 | 0.223 | Interleukin 2 agonist | 0.202 0.186 CID_82341 | ||
| 0.091 | 0.021 | 0.178 | Adrenaline uptake inhibitor | 0.178 0.007 CID_10451115 0.058 0.047 CID_82341 | CID_10451115 | |
| 0.099 | 0.03 | 0.099 | Interferon agonist | 0.071 0.068 CID_10451115 0.082 0.049 CID_82341 | ||
| 0.087 | 0.018 | 0.194 | Dopamine D4 agonist | 0.194 0.007 CID_10451115 | CID_10451115 | |
| 0.089 | 0.02 | 0.214 | Alpha 1 adrenoreceptor agonist | 0.214 0.006 CID_10451115 0.06 0.036 CID_82341 | CID_10451115 | |
| 0.086 | 0.017 | 0.11 | NMDA 2A receptor antagonist | 0.11 0.011 CID_10451115 | CID_10451115 | |
| 0.122 | 0.054 | 0.14 | Calcium channel (voltage-sensitive) blocker | 0.14 0.04 CID_10451115 0.098 0.086 CID_82341 | CID_10451115 | |
| 0.127 | 0.059 | 0.143 | DNA repair enzyme inhibitor | 0.143 0.038 CID_10451115 | CID_10451115 | |
| 0.123 | 0.055 | 0.126 | Transcription factor STAT6 inhibitor | 0.126 0.05 CID_10451115 | CID_10451115 | |
| 0.104 | 0.038 | 0.109 | Glutamate release inhibitor | 0.109 0.032 CID_10451115 | CID_10451115 | |
| 0.095 | 0.03 | 0.247 | Alpha adrenoreceptor agonist | 0.247 0.006 CID_10451115 | CID_10451115 | |
| 0.219 | 0.155 | 0.227 | Antithrombotic | 0.192 0.187 CID_10451115 0.227 0.147 CID_82341 | CID_82341 | |
| 0.087 | 0.025 | 0.087 | Carbamoyl phosphate synthetase inhibitor | 0.077 0.03 CID_82341 | ||
| 0.106 | 0.044 | 0.123 | Calcium antagonist | 0.123 0.033 CID_10451115 | CID_10451115 | |
| 0.135 | 0.073 | 0.22 | Toll-Like receptor 9 antagonist | 0.22 0.028 CID_10451115 0.195 0.038 CID_82341 | CID_10451115 | |
| 0.156 | 0.095 | 0.156 | Amyloid beta precursor protein antagonist | |||
| 0.139 | 0.079 | 0.139 | Heat shock protein 70 antagonist | 0.137 0.087 CID_10451115 | ||
| 0.08 | 0.02 | 0.115 | Sigma receptor antagonist | 0.115 0.014 CID_10451115 0.055 0.031 CID_82341 | CID_10451115 | |
| 0.117 | 0.06 | 0.117 | Estrogen antagonist | |||
| 0.093 | 0.037 | 0.148 | Telomerase inhibitor | 0.115 0.028 CID_10451115 0.148 0.02 CID_82341 | CID_82341 | |
| 0.151 | 0.095 | 0.151 | Dual specificity phosphatase 3 inhibitor | |||
| 0.131 | 0.076 | 0.225 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.225 0.039 CID_10451115 | CID_10451115 | |
| 0.079 | 0.025 | 0.079 | Interferon inducer | 0.059 0.055 CID_10451115 0.066 0.041 CID_82341 | ||
| 0.11 | 0.056 | 0.132 | Beta glucuronidase inhibitor | 0.132 0.036 CID_10451115 | CID_10451115 | |
| 0.075 | 0.021 | 0.122 | CC chemokine 2 receptor antagonist | 0.122 0.009 CID_10451115 0.057 0.036 CID_82341 | CID_10451115 | |
| 0.116 | 0.062 | 0.116 | Photosensitizer | 0.109 0.073 CID_10451115 | ||
| 0.165 | 0.113 | 0.165 | Insulin sensitizer | |||
| 0.065 | 0.012 | 0.065 | Dopamine D3 agonist | 0.061 0.014 CID_10451115 0.045 0.022 CID_82341 | ||
| 0.077 | 0.025 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.06 0.055 CID_10451115 | ||
| 0.185 | 0.134 | 0.217 | Cardiotonic | 0.217 0.104 CID_82341 | CID_82341 | |
| 0.152 | 0.101 | 0.162 | Catenin beta inhibitor | 0.162 0.08 CID_10451115 | CID_10451115 | |
| 0.105 | 0.055 | 0.105 | Insulin receptor antagonist | 0.096 0.067 CID_10451115 | ||
| 0.076 | 0.026 | 0.145 | 5 Hydroxytryptamine 5A antagonist | 0.145 0.008 CID_10451115 | CID_10451115 | |
| 0.074 | 0.026 | 0.176 | 5 Hydroxytryptamine 6 antagonist | 0.176 0.004 CID_10451115 | CID_10451115 | |
| 0.211 | 0.163 | 0.225 | Vasodilator, peripheral | 0.224 0.15 CID_10451115 0.225 0.149 CID_82341 | CID_82341 | |
| 0.082 | 0.036 | 0.087 | Vanilloid 4 agonist | 0.087 0.03 CID_10451115 | CID_10451115 | |
| 0.073 | 0.027 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.02 CID_10451115 0.049 0.046 CID_82341 | CID_10451115 | |
| 0.056 | 0.01 | 0.056 | p53 inhibitor | 0.055 0.011 CID_10451115 0.05 0.014 CID_82341 | ||
| 0.183 | 0.138 | 0.226 | Superoxide dismutase inhibitor | 0.226 0.092 CID_10451115 | CID_10451115 | |
| 0.222 | 0.182 | 0.339 | GABA C receptor rho-3 antagonist | 0.339 0.092 CID_10451115 | CID_10451115 | |
| 0.102 | 0.062 | 0.102 | Estrogen receptor beta antagonist | |||
| 0.083 | 0.044 | 0.083 | Estrogen receptor alpha antagonist | |||
| 0.071 | 0.032 | 0.102 | NMDA 2C receptor antagonist | 0.102 0.015 CID_10451115 | CID_10451115 | |
| 0.066 | 0.03 | 0.141 | 5 Hydroxytryptamine 5 antagonist | 0.141 0.009 CID_10451115 | CID_10451115 | |
| 0.194 | 0.159 | 0.322 | Thyroid hormone beta antagonist | 0.194 0.16 CID_10451115 0.322 0.078 CID_82341 | CID_82341 | |
| 0.145 | 0.11 | 0.203 | 3C-like protease (Human coronavirus) inhibitor | 0.203 0.05 CID_10451115 | CID_10451115 | |
| 0.06 | 0.025 | 0.085 | Dopamine transporter inhibitor | 0.085 0.015 CID_10451115 | CID_10451115 | |
| 0.049 | 0.015 | 0.049 | Heme oxygenase inhibitor | 0.046 0.02 CID_10451115 | ||
| 0.133 | 0.099 | 0.133 | Hexokinase inhibitor | |||
| 0.073 | 0.039 | 0.152 | 5 Hydroxytryptamine 3A antagonist | 0.152 0.005 CID_10451115 | CID_10451115 | |
| 0.11 | 0.077 | 0.145 | Interleukin 8 antagonist | 0.145 0.037 CID_10451115 | CID_10451115 | |
| 0.162 | 0.129 | 0.162 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.155 0.136 CID_10451115 | ||
| 0.055 | 0.023 | 0.055 | Dopamine D2 agonist | 0.05 0.027 CID_10451115 0.045 0.03 CID_82341 | ||
| 0.044 | 0.013 | 0.049 | ATM kinase inhibitor | 0.049 0.009 CID_10451115 | CID_10451115 | |
| 0.076 | 0.045 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.071 0.059 CID_10451115 | ||
| 0.059 | 0.03 | 0.081 | Myc inhibitor | 0.081 0.013 CID_10451115 | CID_10451115 | |
| 0.094 | 0.065 | 0.094 | MAP kinase kinase 1 inhibitor | |||
| 0.102 | 0.074 | 0.12 | GABA receptor agonist | 0.12 0.057 CID_82341 | CID_82341 | |
| 0.056 | 0.035 | 0.056 | Thromboxane synthase inhibitor | 0.051 0.046 CID_82341 | ||
| 0.19 | 0.17 | 0.321 | Thyroid hormone antagonist | 0.187 0.173 CID_10451115 0.321 0.084 CID_82341 | CID_82341 | |
| 0.133 | 0.115 | 0.133 | Dual specificity phosphatase inhibitor | |||
| 0.096 | 0.078 | 0.096 | DNA intercalator | 0.095 0.078 CID_10451115 | ||
| 0.033 | 0.015 | 0.041 | Sigma 1 receptor antagonist | 0.041 0.012 CID_10451115 0.029 0.017 CID_82341 | CID_10451115 | |
| 0.033 | 0.015 | 0.038 | Sigma 2 receptor antagonist | 0.038 0.013 CID_10451115 0.025 0.02 CID_82341 | CID_10451115 | |
| 0.168 | 0.151 | 0.168 | Interleukin agonist | |||
| 0.047 | 0.031 | 0.052 | CC chemokine 4 receptor antagonist | 0.046 0.035 CID_10451115 0.052 0.025 CID_82341 | CID_82341 | |
| 0.06 | 0.044 | 0.079 | Acetylcholine M2 receptor antagonist | 0.079 0.03 CID_10451115 | CID_10451115 | |
| 0.083 | 0.069 | 0.083 | NADH dehydrogenase inhibitor | |||
| 0.058 | 0.045 | 0.097 | Cannabinoid CB1 receptor agonist | 0.097 0.021 CID_82341 | CID_82341 | |
| 0.057 | 0.045 | 0.077 | Acetylcholine M3 receptor antagonist | 0.077 0.028 CID_10451115 | CID_10451115 | |
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.188 | 0.178 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.288 0.052 CID_10451115 | CID_10451115 | |
| 0.077 | 0.068 | 0.091 | Caspase 7 inhibitor | 0.091 0.04 CID_10451115 | CID_10451115 | |
| 0.058 | 0.048 | 0.058 | NMDA receptor glycine site agonist | |||
| 0.088 | 0.08 | 0.088 | Phosphodiesterase 6D inhibitor | |||
| 0.035 | 0.027 | 0.035 | Ceramide glucosyltransferase inhibitor | |||
| 0.053 | 0.045 | 0.201 | 5 Hydroxytryptamine 3 antagonist | 0.201 0.005 CID_10451115 | CID_10451115 | |
| 0.042 | 0.035 | 0.163 | 5 Hydroxytryptamine 1A agonist | 0.163 0.01 CID_10451115 | CID_10451115 | |
| 0.031 | 0.025 | 0.035 | Protein kinase C beta II inhibitor | 0.035 0.017 CID_10451115 | CID_10451115 | |
| 0.029 | 0.024 | 0.044 | Endothelial nitric-oxide synthase inhibitor | 0.044 0.011 CID_10451115 | CID_10451115 | |
| 0.051 | 0.046 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.042 CID_10451115 | CID_10451115 | |
| 0.046 | 0.04 | 0.063 | Potassium channel (Inward rectifier) blocker | 0.063 0.022 CID_82341 | CID_82341 | |
| 0.02 | 0.016 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.049 | 0.045 | 0.049 | Alpha-mannosidase inhibitor | |||
| 0.094 | 0.091 | 0.14 | MAP kinase 13 inhibitor | 0.14 0.041 CID_10451115 | CID_10451115 | |
| 0.08 | 0.077 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 CID_10451115 | CID_10451115 | |
| 0.138 | 0.135 | 0.138 | Non-steroidal antiinflammatory agent | |||
| 0.097 | 0.095 | 0.113 | Acetylcholine release stimulant | 0.113 0.061 CID_10451115 | CID_10451115 | |
| 0.05 | 0.048 | 0.05 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.037 | 0.036 | 0.037 | Thymidine kinase inhibitor | |||
| 0.062 | 0.061 | 0.096 | NMDA 2 receptor antagonist | 0.096 0.034 CID_10451115 | CID_10451115 | |
| 0.178 | 0.18 | 0.192 | Tyrosine 3 hydroxylase inhibitor | 0.192 0.151 CID_10451115 | CID_10451115 | |
| 0.107 | 0.109 | 0.145 | Toll-Like receptor antagonist | 0.121 0.083 CID_10451115 0.145 0.059 CID_82341 | CID_82341 | |
| 0.047 | 0.052 | 0.057 | Lysine-specific demethylase 1A inhibitor | 0.057 0.032 CID_10451115 | CID_10451115 | |
| 0.121 | 0.129 | 0.134 | Pregnane X receptor agonist | 0.134 0.089 CID_10451115 | CID_10451115 | |
| 0.058 | 0.066 | 0.088 | Protein kinase C alpha inhibitor | 0.088 0.028 CID_10451115 | CID_10451115 | |
| 0.029 | 0.037 | 0.073 | 5 Hydroxytryptamine 3B antagonist | 0.073 0.008 CID_10451115 | CID_10451115 | |
| 0.034 | 0.045 | 0.053 | NMDA receptor subunit 3B antagonist | 0.053 0.023 CID_10451115 | CID_10451115 | |
| 0.082 | 0.093 | 0.117 | Nitric-oxide synthase inhibitor | 0.117 0.04 CID_10451115 | CID_10451115 | |
| 0.129 | 0.141 | 0.189 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.189 0.082 CID_10451115 | CID_10451115 | |
| 0.049 | 0.061 | 0.068 | Cannabinoid receptor agonist | 0.068 0.042 CID_82341 | CID_82341 | |
| 0.066 | 0.079 | 0.074 | Adrenaline agonist | 0.074 0.067 CID_10451115 | CID_10451115 | |
| 0.142 | 0.156 | 0.157 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.157 0.134 CID_10451115 | CID_10451115 | |
| 0.041 | 0.055 | 0.054 | CC chemokine receptor 2B antagonist | 0.054 0.025 CID_10451115 | CID_10451115 | |
| 0.093 | 0.108 | 0.111 | Calcium channel N-type blocker | 0.111 0.076 CID_10451115 | CID_10451115 | |
| 0.063 | 0.08 | 0.13 | Acetylcholine nicotinic antagonist | 0.13 0.027 CID_10451115 | CID_10451115 | |
| 0.02 | 0.037 | 0.048 | Acetylcholine M4 receptor agonist | 0.048 0.012 CID_10451115 | CID_10451115 | |
| 0.028 | 0.047 | 0.045 | Benzodiazepine receptor peripheral-type antagonist | 0.033 0.027 CID_10451115 0.045 0.009 CID_82341 | CID_82341 | |
| 0.021 | 0.041 | 0.039 | Myristoyl transferase inhibitor | 0.039 0.006 CID_10451115 | CID_10451115 | |
| 0.131 | 0.155 | 0.197 | Potassium channel blocker | 0.197 0.095 CID_10451115 0.168 0.117 CID_82341 | CID_10451115 | |
| 0.046 | 0.072 | 0.323 | 5 Hydroxytryptamine agonist | 0.323 0.007 CID_10451115 | CID_10451115 | |
| 0.038 | 0.066 | 0.05 | Benzodiazepine antagonist | 0.05 0.027 CID_10451115 | CID_10451115 | |
| 0.077 | 0.105 | 0.086 | Electrolyte absorption antagonist | 0.086 0.081 CID_10451115 | CID_10451115 | |
| 0.023 | 0.052 | 0.036 | NMDA receptor subunit 3A antagonist | 0.036 0.029 CID_10451115 | CID_10451115 | |
| 0.203 | 0.233 | 0.257 | Analgesic | 0.257 0.176 CID_10451115 | CID_10451115 | |
| 0.064 | 0.096 | 0.138 | Acetylcholine agonist | 0.138 0.03 CID_10451115 | CID_10451115 | |
| 0.014 | 0.046 | 0.026 | Cyclin E2 inhibitor | 0.026 0.022 CID_10451115 | CID_10451115 | |
| 0.031 | 0.064 | 0.039 | Nerve growth factor antagonist | 0.039 0.038 CID_10451115 | CID_10451115 | |
| 0.07 | 0.103 | 0.123 | Chemokine receptor antagonist | 0.123 0.046 CID_10451115 0.087 0.078 CID_82341 | CID_10451115 | |
| 0.251 | 0.286 | 0.302 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.302 0.21 CID_10451115 | CID_10451115 | |
| 0.022 | 0.058 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.022 CID_82341 | CID_82341 | |
| 0.03 | 0.066 | 0.051 | Phenylethanolamine N methyltransferase inhibitor | 0.051 0.014 CID_10451115 | CID_10451115 | |
| 0.021 | 0.061 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.023 CID_82341 | CID_82341 | |
| 0.054 | 0.096 | 0.062 | Calcium channel P-type blocker | 0.062 0.05 CID_82341 | CID_82341 | |
| 0.034 | 0.077 | 0.065 | Acetylcholine muscarinic agonist | 0.065 0.03 CID_10451115 | CID_10451115 | |
| 0.03 | 0.074 | 0.047 | Melanin-concentrating hormone receptor 1 antagonist | 0.047 0.044 CID_10451115 | CID_10451115 | |
| 0.159 | 0.205 | 0.22 | Hypoxia-inducible factor 1 alpha inhibitor | 0.22 0.129 CID_10451115 | CID_10451115 | |
| 0.04 | 0.086 | 0.064 | Acetylcholine M5 receptor agonist | 0.064 0.051 CID_10451115 | CID_10451115 | |
| 0.097 | 0.144 | 0.146 | Cholinergic | 0.146 0.08 CID_10451115 | CID_10451115 | |
| 0.048 | 0.097 | 0.07 | CXC chemokine receptor antagonist | 0.07 0.049 CID_10451115 | CID_10451115 | |
| 0.023 | 0.073 | 0.03 | Vanilloid 4 antagonist | 0.03 0.028 CID_10451115 | CID_10451115 | |
| 0.072 | 0.122 | 0.226 | 5 Hydroxytryptamine 3A agonist | 0.226 0.009 CID_10451115 | CID_10451115 | |
| 0.068 | 0.119 | 0.083 | Polo-like kinase-1 inhibitor | 0.083 0.077 CID_10451115 | CID_10451115 | |
| 0.101 | 0.153 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.062 CID_82341 | CID_82341 | |
| 0.039 | 0.09 | 0.063 | Cyclin D1 inhibitor | 0.063 0.038 CID_10451115 | CID_10451115 | |
| 0.025 | 0.078 | 0.102 | 5 Hydroxytryptamine 1 agonist | 0.102 0.02 CID_10451115 | CID_10451115 | |
| 0.032 | 0.09 | 0.067 | Nicotinic alpha7 receptor agonist | 0.067 0.025 CID_10451115 | CID_10451115 | |
| 0.022 | 0.079 | 0.052 | Acetylcholine M1 receptor agonist | 0.052 0.025 CID_10451115 | CID_10451115 | |
| 0.03 | 0.09 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 CID_82341 | CID_82341 | |
| 0.026 | 0.088 | 0.05 | Thromboxane antagonist | 0.05 0.042 CID_82341 | CID_82341 | |
| 0.05 | 0.115 | 0.131 | Acetylcholine nicotinic agonist | 0.131 0.023 CID_10451115 | CID_10451115 | |
| 0.139 | 0.204 | 0.254 | 5 Hydroxytryptamine release stimulant | 0.254 0.087 CID_10451115 | CID_10451115 | |
| 0.032 | 0.098 | 0.079 | Histamine H4 receptor antagonist | 0.079 0.009 CID_10451115 | CID_10451115 | |
| 0.058 | 0.127 | 0.181 | Protein kinase C mu inhibitor | 0.181 0.015 CID_10451115 | CID_10451115 | |
| 0.028 | 0.097 | 0.127 | 5 Hydroxytryptamine 2 agonist | 0.127 0.006 CID_10451115 | CID_10451115 | |
| 0.045 | 0.115 | 0.078 | CC chemokine receptor antagonist | 0.078 0.053 CID_10451115 | CID_10451115 | |
| 0.013 | 0.084 | 0.038 | Potassium channel small-conductance Ca-activated activator | 0.038 0.016 CID_10451115 | CID_10451115 | |
| 0.02 | 0.093 | 0.042 | Dopamine D5 agonist | 0.042 0.026 CID_10451115 | CID_10451115 | |
| 0.026 | 0.1 | 0.054 | Protein kinase C epsilon inhibitor | 0.054 0.036 CID_10451115 | CID_10451115 | |
| 0.026 | 0.108 | 0.088 | Nicotinic neuronal receptor agonist | 0.088 0.017 CID_10451115 | CID_10451115 | |
| 0.167 | 0.25 | 0.293 | Antiobesity | 0.293 0.121 CID_10451115 | CID_10451115 | |
| 0.172 | 0.255 | 0.22 | Ca(v)3.3 blocker | 0.22 0.152 CID_10451115 | CID_10451115 | |
| 0.067 | 0.15 | 0.12 | MAP kinase 12 inhibitor | 0.12 0.07 CID_10451115 | CID_10451115 | |
| 0.034 | 0.119 | 0.121 | Leukotriene synthesis inhibitor | 0.121 0.016 CID_82341 | CID_82341 | |
| 0.029 | 0.115 | 0.104 | 5 Hydroxytryptamine 1D antagonist | 0.104 0.021 CID_10451115 | CID_10451115 | |
| 0.173 | 0.261 | 0.242 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.242 0.076 CID_10451115 | CID_10451115 | |
| 0.101 | 0.192 | 0.175 | Tumour necrosis factor antagonist | 0.175 0.072 CID_10451115 | CID_10451115 | |
| 0.138 | 0.23 | 0.168 | Peptidyltransferase inhibitor | 0.168 0.151 CID_82341 | CID_82341 | |
| 0.048 | 0.14 | 0.088 | Glycine receptor antagonist | 0.088 0.045 CID_10451115 | CID_10451115 | |
| 0.01 | 0.104 | 0.031 | Carnitine palmitoyltransferase 1A inhibitor | 0.031 0.016 CID_82341 | CID_82341 | |
| 0.064 | 0.16 | 0.081 | CC chemokine 5 receptor agonist | 0.081 0.06 CID_10451115 | CID_10451115 | |
| 0.051 | 0.148 | 0.101 | Neuropeptide Y antagonist | 0.101 0.04 CID_10451115 | CID_10451115 | |
| 0.138 | 0.236 | 0.283 | Beta lactamase inhibitor | 0.283 0.142 CID_82341 | CID_82341 | |
| 0.075 | 0.177 | 0.112 | Protein kinase C nu inhibitor | 0.112 0.102 CID_10451115 | CID_10451115 | |
| 0.051 | 0.156 | 0.098 | Protein kinase C delta inhibitor | 0.098 0.054 CID_10451115 | CID_10451115 | |
| 0.12 | 0.227 | 0.164 | DNA damaging | 0.164 0.153 CID_10451115 | CID_10451115 | |
| 0.013 | 0.125 | 0.033 | 5 Hydroxytryptamine 6 agonist | 0.033 0.012 CID_10451115 | CID_10451115 | |
| 0.025 | 0.139 | 0.091 | 5 Hydroxytryptamine 2A agonist | 0.091 0.019 CID_10451115 | CID_10451115 | |
| 0.031 | 0.159 | 0.065 | 5 Hydroxytryptamine 7 agonist | 0.065 0.024 CID_10451115 | CID_10451115 | |
| 0.031 | 0.161 | 0.103 | Nicotinic alpha4beta2 receptor antagonist | 0.103 0.029 CID_10451115 | CID_10451115 | |
| 0.035 | 0.169 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.051 CID_10451115 | CID_10451115 | |
| 0.061 | 0.202 | 0.111 | Alpha 2d adrenoreceptor antagonist | 0.111 0.033 CID_10451115 | CID_10451115 | |
| 0.031 | 0.176 | 0.047 | Alpha 1b adrenoreceptor agonist | 0.047 0.042 CID_10451115 | CID_10451115 | |
| 0.027 | 0.178 | 0.056 | Protein kinase C iota inhibitor | 0.056 0.044 CID_10451115 | CID_10451115 | |
| 0.065 | 0.217 | 0.239 | Interleukin 1 antagonist | 0.239 0.021 CID_82341 | CID_82341 | |
| 0.024 | 0.209 | 0.057 | Alpha 1L adrenoreceptor agonist | 0.057 0.01 CID_10451115 | CID_10451115 | |
| 0.016 | 0.209 | 0.042 | Histamine H1 receptor agonist | 0.042 0.034 CID_10451115 | CID_10451115 | |
| 0.017 | 0.217 | 0.061 | Alpha 2 adrenoreceptor agonist | 0.061 0.041 CID_10451115 | CID_10451115 | |
| 0.016 | 0.218 | 0.041 | 5 Hydroxytryptamine 2B agonist | 0.041 0.023 CID_10451115 | CID_10451115 | |
| 0.02 | 0.225 | 0.045 | Purinergic P2X4 antagonist | 0.045 0.033 CID_10451115 | CID_10451115 | |
| 0.007 | 0.227 | 0.107 | 5 Hydroxytryptamine 2C agonist | 0.107 0.007 CID_10451115 | CID_10451115 | |
| 0.049 | 0.349 | 0.147 | Interleukin antagonist | 0.147 0.12 CID_82341 | CID_82341 | |
| 0.005 | 0.317 | 0.049 | Beta tubulin antagonist | 0.049 0.047 CID_82341 | CID_82341 | |
| 0.045 | 0.435 | 0.165 | Tumour necrosis factor alpha release inhibitor | 0.165 0.139 CID_82341 | CID_82341 | |
| 0.025 | 0.566 | 0.174 | Interleukin 1b antagonist | 0.174 0.027 CID_82341 | CID_82341 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |